XML 40 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Description of Business and Basis of Presentation (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 17, 2024
Feb. 27, 2024
Sep. 30, 2024
Sep. 30, 2024
Mar. 05, 2024
Feb. 28, 2024
Feb. 28, 2024
Feb. 28, 2024
Dec. 31, 2023
Nov. 20, 2023
Organization Consolidation And Presentation Of Financial Statements [Line Items]                    
Cash and cash equivalents     $ 41,571 $ 41,571         $ 9,446  
Retained earnings (accumulated deficit)     (296,084) (296,084)         $ (281,042)  
Entity public float, threshold             $ 75,000      
Percent of public float           33.30%   3.00%    
Parent Company                    
Organization Consolidation And Presentation Of Financial Statements [Line Items]                    
Cash and cash equivalents     $ 28,900 $ 28,900            
Private Placement                    
Organization Consolidation And Presentation Of Financial Statements [Line Items]                    
Proceeds from issuance of private placement   $ 51,000                
Private placement, shares (in shares)         116,493          
Private placement pre-funded warrants, shares (in shares)         116,590          
Private Placement | Private Placement Pre-Funded Warrants                    
Organization Consolidation And Presentation Of Financial Statements [Line Items]                    
Exercise price of warrants or rights (in usd per share)   $ 0.01                
Class A Common Stock                    
Organization Consolidation And Presentation Of Financial Statements [Line Items]                    
Common stock par value (in usd per share)     $ 0.01 $ 0.01         $ 0.01 $ 0.01
Shares sold (in shares) 179,400                  
Sale of stock, consideration received on transaction $ 2,500                  
Class A Common Stock | Private Placement                    
Organization Consolidation And Presentation Of Financial Statements [Line Items]                    
Shares sold (in shares)   464,377                
Sale of stock, price per share (in usd per share)   $ 11.81                
Class A Common Stock | Private Placement | Private Placement Pre-Funded Warrants                    
Organization Consolidation And Presentation Of Financial Statements [Line Items]                    
Sale of stock, price per share (in usd per share)   $ 11.80                
Number of securities called by warrants or rights (in shares)   3,853,997 3,970,587 3,970,587            
Class A Common Stock | TD Cowen Sales Agreement                    
Organization Consolidation And Presentation Of Financial Statements [Line Items]                    
Shares sold (in shares)     179,400 179,400            
Aggregate offering price             $ 50,000      
Sale of stock, consideration received on transaction     $ 2,500 $ 2,500            
Class B Common Stock                    
Organization Consolidation And Presentation Of Financial Statements [Line Items]                    
Common stock par value (in usd per share)     $ 0.01 $ 0.01         $ 0.01 $ 0.01
vTv Therapeutics LLC                    
Organization Consolidation And Presentation Of Financial Statements [Line Items]                    
Percentage of non-voting economic interest of vTv Therapeutics Holdings LLC in vTv LLC       18.10%            
Percentage of non-voting economic interest of vTv Therapeutics Inc in vTv LLC       81.90%            
vTv Therapeutics LLC | Class B Common Stock                    
Organization Consolidation And Presentation Of Financial Statements [Line Items]                    
Common stock par value (in usd per share)     $ 0.01 $ 0.01